CRDF — Cardiff Oncology Inc · rev $145.0K

Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.

Latest reported CRDF revenue for 2026-06-30 was $145.0K. Net income was -$21.6M. CRDF currently screens at market cap $238.8M.

Use this CRDF page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CRDF quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CRDF SEC filings page. Lician reads the product cache first so this HTML stays unique to Cardiff Oncology Inc even when a live quote feed is slow.

Cardiff Oncology Inc latest statements (FY2025)

Latest cached year on this hub. Full CRDF income, balance, and cash tables.

  • Revenue$593.0K
  • Net Income-$45.9M
  • Total Assets$61.9M
  • Total Debt$0
  • Free Cash Flow-$38.0M

CRDF recent filings